We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

90 hedge funds and large institutions have $277M invested in Cardiovascular Systems, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $808K | Put options by funds: $365K

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 8890 (+2)

3% less capital invested

Capital invested by funds: $286M → $277M (-$9.93M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
2.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
11
Increased
39
Reduced
24
Closed
8
Calls
$808K
Puts
$365K
Net Calls
+$443K
Net Calls Change
+$443K

CSII Hedge Fund Activity: Q3 2013 in Review

90 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2013, worth a combined $277M — down 3.5% from $286M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CSII positions and 8 closed out — a net gain of 3 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $5.32M. The largest seller was Castleark Management, exiting entirely with an estimated $3.35M sold.

  • 90 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2013, up from 88 in Q2 2013.
  • Funds reported $277M of Cardiovascular Systems, Inc. stock for Q3 2013, down 3.5% quarter-over-quarter.
  • 11 funds opened new Cardiovascular Systems, Inc. positions in Q3 2013 and 8 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2013 was Consonance Capital Management, an estimated $5.32M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2013 was Castleark Management, an estimated $3.35M sold.

Based on aggregated 13F filings for Q3 2013.